Michele Cavalleri - Eurofins Biolab, Chairman
GLP Facility Manager of the Biocidal Products Division in Eurofins Biolab (Italy). He has gained a solid expertise on efficay assessment of disinfectants. He is also member of the European Committee CEN TC 216 that establishes standardized methods of test and requirements for the antimicrobial efficacy of chemical disinfectants and antiseptics.
Maristella Rubbiani - National Seconded Expert at EU COM - DG
Sante - Pesticides and Biocides Unit
Maristella is a member of the CA, BPC Committee and the national Committee for
authorization of biocides and PPPs. She is responsible of the national database for poison
centres according to Art 45 CLP and has more than 30 years of experience in regulatory
toxicology and C&L for risk assessment of substances and preparations. She has a degree in Biology and a PhD in Industrial and Environmental Hygiene.
Lucilla Cataldi - Istituto Superiore della Sanità (ISS), Rome - Italy
With a degree in chemistry joined Istituto Superiore della Sanità (ISS, Rome) in 2003 as a scientist. Since 2005, has worked in the evaluation of technical dossiers and drafting of Competent Authority Reports (CARs) for the inclusion/approval of active substances assigned to Italy under the Review Programme for Biocides. Evaluation of technical dossiers and drafting of Product Assessment Reports (Pars) for the authorization of biocidal products at national level since 2009. BPC-APCP-Working Group flexible member at ECHA since 2013.
Daniela Romano - Eurofins Biolab
After her PhD in Biophysics and a Post Doc position in medical research, Daniela has been working with Eurofins, mainly on Biocides, since 2003. She was first in charge of stability studies and then the management of the Chemistry laboratory. She managed projects aiming towards Biocidal Products authorisation for several years and is now also involved in the risk assessment procedures. She has sound experience with a large variety of biocidal products.
Darren Abrahams - Partner, Steptoe & Johnson LLP, Belgium
Darren enables clients throughout the chemicals and life sciences supply chain to get and keep their products on the European Union market. He focuses on defense of products through strategic advice, advocacy before institutions and agencies, and litigation before EU and national courts and tribunals. He has a wealth of experience with the EU regulation of biocidal products, plant protection products (agrochemicals), REACH, classification, labelling and packaging, GM food and feed, cosmetics, and endocrine disruptors.
Peter Kugel - VVGB Advocaten Brussels
Peter is a specialist in Environmental, Health & Safety Risk Regulation and has a broad EU Regulatory & Litigation practice in environment, chemicals, food and drug law. He is a partner in the EU, Trade & Competition team.
Anna-Kristina Rudolph - knoell Germany GmbH
Kristina joined knoell’s Efficacy Task Force in 2017. Since then she has been working as an efficacy expert and regulatory manager for biocides, thereby supporting clients in projects ranging from active substance approvals to authorisations of complex biocidal product families. One of her main areas of expertise is the development of customized efficacy testing strategies for biocides.
Other industry experts to be defined soon.
BPR: From regulation to implementation.
How to deal with biocidal products
9:15 Welcome and introduction
Chairman, Michele Cavalleri, GLP/ISO 17025 Test Facility Manager at Eurofins Biolab, Italy
Session 1: Regulatory aspects framework
9:30 Implementation of the evaluation criteria for Endocrine Disruptors in the light of BPR Regulation 528/2012:
· The EU COM strategy for Endocrine Disruptors
· Application of the guideline
· Impact on dossier evaluation
· Update on next steps and future perspective
Maristella Rubbiani, National Seconded Expert at EU COM - DG Sante - Pesticides and Biocides Unit
10:10 What’s new on Biocidal Product Families from the BPF working group
Industry expert (To be defined)
10:50 Question & Answers
11:00 Coffee break
Session 2: Product Authorisation Practical aspects
11:30 Best practice for a product family authorisation:
· The concept of chemical similarity of BPF
· Backbone’ composition of the family products
· Grouping of co-formulants
Lucilla Cataldi, ISS, Italy
12:10 The practical CRO and Consultant point of view in BPF authorisation: Do’s and Don’ts
Daniela Romano, Regulatory Affair Manager for Biocidal Products, Eurofins Biolab, Italy
12:50 Lunch break
14:00 Experience in BPF product authorization from a Company perspective
Industry expert (to be defined)
14:40 Question & Answers
Session 3: Legal/regulatory issues
14:50 Post Brexit scenario
· Implications for compliance strategies and supply chains
· Data sharing issues
· The UK biocides regime
Darren Abrahams, Partner, Steptoe & Johnson LLP, Belgium
15:30 Coffee break
16:00 BPR regulation legal challenges and impact on Industries
Peter Kugel, VVGB Advocaten Brussels
16:40 BPR – what next from a regulatory point of view?
· Implications of legislative and guidance changes
· Progress and challenges of the review programme
· Initiatives for industry
· The future of the biocides market
Anna-Kristina Rudolph, knoell Germany
17:20 - 17:30 Questions and answers
We will organize in the relaxing area of Melià at the end of the Conference a refreshment for speakers and delegates. Please confirm your presence while submitting.
Planning a biocidal product family authorization:
Quaternary ammonium compound
A biocidal product family consists of multiple products with different concentrations of the same active substance. All products within a biocidal product family are covered by one authorisation under the Biocidal Products Regulation.
The basic product requirements for a product family are:
Identical active substance(s)
Similar compositions with defined limits
Similar hazard profile
For all applications data must be generated as specified in Annex III BPR for the product or the products from the family. This Workshop aims to provide a fully understanding of all the aspects related to the strategic planning of a biocidal product family.
Agenda (9.30h - 12.30h)
09:30 General Introduction: Biocidal Product Family concept
09:45 Strategic and technical aspects to be evaluated when planning of a biocidal product family
10:30 Case Study: Introduction of a number of products to be allegedly inserted in the family
10:45 Coffee break
11:00 Case Study: Data gap analysis and structuring of the biocidal product family. How to outline the testing plan by identifying the most appropriate product to use for different tests
12:15 - 12:30 Questions and answers
Daniela Romano, Regulatory Affair Manager for Biocidal Products, Eurofins Biolab, Italy
Early bird price - Valid until July 26, 2019
- Conference and Workshop: 280€ + VAT (VAT applicable to italian companies only)
- Conference attendance only (September 26, 2019): *210€ + VAT (VAT applicable to italian companies only)
- Workshop attendance only (September 27, 2019): **90€ + VAT (VAT applicable to italian companies only
Full price - Valid after July 26, 2019
- Conference and Workshop:
370€ + VAT (if applicable) - First delegate; 330€ + VAT (if applicable) - Second delegate
- Conference attendance only (September 26, 2019):
*300€ + VAT (if applicable) - First delegate *260€ + VAT (if applicable) - Second delegate
- Workshop attendance only (September 27, 2019):
**110€ + VAT (if applicable) - First delegate; **100€ + VAT (if applicable) - Second delegate
*Day 1: Lunch included
**Day 2: Lunch not included
General terms and conditions
The registration fee is payable in advance. Only after we have received your payment, you are entitled to attend the Conference and/or Workshop. A certificate of attendance for professional development will be given to each participant who completes the Conference and/or Workshop.
If you cannot attend the Conference/Workshop you have two options:
1. We are happy to welcome a substitute colleague at any time.
2. If you have to cancel entirely we must charge the following processing fees:
- until 1 week prior to the conference 50% of the registration fee will be charged;
- less than 1 week prior to the conference fullregistration fee will be charged.
Eurofins BioPharma Product Testing Italy reserves the right to cancel/alter the programme, the
speakers, the date or venue. If the event must be cancelled, registrants will be notified as soon as
possible and will receive a full refund of fees paid. Eurofins BioPharma Product Testing Italy is not
responsible for airfare, hotel or other costs incurred by registered delegates. Your data will be processed in accordance with EU regulation no. 679 of 27 April 2016 and Legislative Decree 30 June 2003, n. 196.
Eurofins BioPharma Product Testing Italy
Via Bruno Buozzi, 2
20090 - Vimodrone (MI)
Tel. + 39 0225071535
Fax +39 0225071599